Adverse Outcome Pathway - Study Report
The aim of the study was focused on learning more about the uptake of the Adverse Outcome Pathway (AOP) Framework in settings where decisions are taken about chemical safety and toxicity, and where policy is formed. For this reason the study focused on stakeholders in industry and in regulatory agencies, working in regulatory toxicology, risk assessment or risk management. The questions we were tasked with finding answers to related to the extent of the uptake of the framework, what facilitated it and what, instead, challenged it.
CARUSI Annamaria;
SANCHEZ DORADO Julia;
SÖZÜDOĞRU Erman;
WITTWEHR Clemens;
WHELAN Maurice;
2022-02-07
Publications Office of the European Union
JRC127229
978-92-76-45228-7 (online),
1831-9424 (online),
EUR 30925 EN,
OP KJ-NA-30925-EN-N (online),
https://publications.jrc.ec.europa.eu/repository/handle/JRC127229,
10.2760/476003 (online),
Additional supporting files
| File name | Description | File type | |
|---|
